Novel aspects of dopamine oxidative metabolism (Confounding outcomes take place of certainties)

Pharmacology and Toxicology

Volumn 89, Issue 5, 2001, Pages 217-224

  Fornai, Francesco ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 1,2,3,4,6,7 HEXAHYDRO 2 HYDROXY 3 ISOBUTYL 9,10 DIMETHOXY 11BH BENZO[A]QUINOLIZINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; DIHYDROXYPHENYLACETALDEHYDE; DOPAMINE; DOPAMINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; ISOENZYME; LAZABEMIDE; LEVODOPA; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; PARGYLINE; SELEGILINE; UNCLASSIFIED DRUG; VANOXERINE;

AEROBIC METABOLISM; CELL COMPARTMENTALIZATION; DIALYSIS; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LOCALIZATION; IN VITRO STUDY; IN VIVO STUDY; METABOLITE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SPECIES DIFFERENTIATION; TISSUE SPECIFICITY;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0035171590     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.2001.890501.x     Document Type: Short Survey

References (3)

1. Berry, M. D., A. V. Juorio & I. A. Paterson: The functional role of monoamine oxidase A and B in the mammalian central nervous system. Prog. Neurobiol 1994, 42, 375-391.
2. Boulton, A. A. & G. Eisenhofer: Catecholamine metabolism: From molecular understanding to clinical diagnosis and treatment. In: Catecholamines, Bridging basis science with clinical medecine. Eds.: D.S. Goldstein, G. Eisenhofer & R. McCarty. Academic Press, San Diego, 1998, 273-292.
3. Cases, O., I. Seif, J. Grimsby, P. Caspar, K. Chen, S. Pournin, U. Muller, M. Aguet, C. Babinet, J. Shih & E. De Maeyer: Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO-A. Science 1995, 268, 1763-1766.